FDA Approved Products
6,646 products with lifecycle intelligence, competitive pressure scores, and patent timelines.
ELOCON
mometasone furoate
LOE Approaching
Merck & Co.
TOPICAL · OINTMENT
1987
NDA30/100
ELOXATIN
oxaliplatin
LOE Approaching
Sanofi
INTRAVENOUS · INJECTABLE
colorectal cancer
2002
NDA30/100
EMADINE
emedastine difumarate
LOE Approaching
Novartis
OPHTHALMIC · SOLUTION/DROPS
1997
NDA30/100
EMCYT
estramustine phosphate sodium
LOE Approaching
Pfizer
ORAL · CAPSULE
1981
NDA30/100
EMEND
fosaprepitant dimeglumine
LOE Approaching
Merck & Co.
INTRAVENOUS · POWDER
older for the prevention of: acutedelayed nausea+5
2008
NDA30/100
EMETE-CON
benzquinamide hydrochloride
LOE Approaching
Pfizer
INJECTION · INJECTABLE
1974
NDA30/100
EMETE-CON
benzquinamide hydrochloride
LOE Approaching
Pfizer
RECTAL · SUPPOSITORY
1978
NDA30/100
EMFLAZA
deflazacort
Peak
PTC Therapeutics
ORAL · SUSPENSION
Duchenne muscular dystrophy (DMD) in patients 2 years of ageolder ()
2017
NDA30/100
EMFLAZA
deflazacort
Peak
PTC Therapeutics
ORAL · TABLET
Duchenne muscular dystrophy (DMD) in patients 2 years of ageolder ()
2017
NDA30/100
EMLA
lidocaine; prilocaine
LOE Approaching
AstraZeneca
TOPICAL · DISC
1998
NDA30/100
EMLA
lidocaine; prilocaine
LOE Approaching
Teva
TOPICAL · CREAM
1992
NDA30/100
EMSAM
selegiline
LOE Approaching
TRANSDERMAL · FILM, EXTENDED RELEASE
major depressive disorder (MDD) ()
2006
NDA30/100
EMSAM
selegiline
LOE Approaching
TRANSDERMAL · SYSTEM
major depressive disorder (MDD) ()
2006
NDA30/100
EMTRIVA
emtricitabine
LOE Approaching
Gilead Sciences
ORAL · CAPSULE
combination with other antiretroviral agents for the treatment of HIV-1 infection
2003
NDA30/100
EMTRIVA
emtricitabine
LOE Approaching
Gilead Sciences
ORAL · SOLUTION
combination with other antiretroviral agents for the treatment of HIV-1 infection
2005
NDA30/100
ENABLEX
darifenacin hydrobromide
LOE Approaching
AbbVie
ORAL · TABLET, EXTENDED RELEASE
overactive bladder with symptoms of urge urinary incontinenceurgency+1
2004
NDA30/100
ENDARI
glutamine
Peak
Emmaus Life Sciences
ORAL · FOR SOLUTION
acute complications of sickle cell disease in adultolder
2017
NDA30/100
ENDOMETRIN
progesterone
LOE Approaching
Ferring Pharmaceuticals
VAGINAL · INSERT
2007
NDA30/100
ENDURON
methyclothiazide
LOE Approaching
AbbVie
ORAL · TABLET
1960
NDA30/100
ENDURONYL
deserpidine; methyclothiazide
LOE Approaching
Abbott
ORAL · TABLET
1961
NDA30/100
ENDURONYL FORTE
deserpidine; methyclothiazide
LOE Approaching
Abbott
ORAL · TABLET
1961
NDA30/100
ENJUVIA
estrogens, conjugated synthetic b
LOE Approaching
Aspen Surgical
ORAL · TABLET
the: Treatment of moderate to severe vasomotor symptoms associated with menopause
2004
NDA30/100
ENJUVIA
estrogens, conjugated synthetic b
LOE Approaching
ORAL · TABLET
the: Treatment of moderate to severe vasomotor symptoms associated with menopause
2004
NDA30/100
ENLON-PLUS
atropine sulfate; edrophonium chloride
LOE Approaching
INJECTION · INJECTABLE
older for: Atropine is an anticholinergic agent indicated in adultsolder for: Cycloplegia () Mydriasis () Penalization of the healthy eye in the treatment of amblyopia () 1
1991
NDA30/100